BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 9665075)

  • 21. Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin.
    Fu F; Thai NL; Li Y; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1996 Apr; 61(8):1228-33. PubMed ID: 8610423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance.
    Li W; Carper K; Liang Y; Zheng XX; Kuhr CS; Reyes JD; Perkins DL; Thomson AW; Perkins JD
    Transplant Proc; 2006 Dec; 38(10):3207-8. PubMed ID: 17175224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model.
    Chiang YJ; Lu L; Fung JJ; Qian S
    Cell Transplant; 2001; 10(3):343-50. PubMed ID: 11437079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microchimerism, dendritic cell progenitors and transplantation tolerance.
    Thomson AW; Lu L; Murase N; Demetris AJ; Rao AS; Starzl TE
    Stem Cells; 1995 Nov; 13(6):622-39. PubMed ID: 8590864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
    Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine liver allograft transplantation: tolerance and donor cell chimerism.
    Qian S; Demetris AJ; Murase N; Rao AS; Fung JJ; Starzl TE
    Hepatology; 1994 Apr; 19(4):916-24. PubMed ID: 8138266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
    Lu L; Rudert WA; Qian S; McCaslin D; Fu F; Rao AS; Trucco M; Fung JJ; Starzl TE; Thomson AW
    J Exp Med; 1995 Aug; 182(2):379-87. PubMed ID: 7629500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
    Li W; Carper K; Zheng XX; Kuhr CS; Reyes JD; Liang Y; Perkins DL; Thomson AW; Perkins JD
    Transplant Proc; 2006 Dec; 38(10):3205-6. PubMed ID: 17175223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells.
    Woo J; Lu L; Rao AS; Li Y; Subbotin V; Starzl TE; Thomson AW
    Transplantation; 1994 Aug; 58(4):484-91. PubMed ID: 8073517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of stable intragraft cell chimerism in rat liver allografts after drug-induced tolerance.
    Gassel HJ; Otto C; Klein I; Steger U; Meyer D; Gassel AM; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2001 Jun; 71(12):1848-52. PubMed ID: 11455268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance.
    Sharland A; Yan Y; Wang C; Bowen DG; Sun J; Sheil AG; McCaughan GW; Bishop GA
    Transplantation; 1999 Dec; 68(11):1736-45. PubMed ID: 10609951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
    Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
    Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Ramadas R; Yeong ML; Benjamin CD; Hess D; Munn SR
    J Surg Res; 2003 Nov; 115(1):1-8. PubMed ID: 14572766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.